Bayer AG’s (BAYN) deal to purchase Merck & Co’s consumer products unit for $14.2 billion will be the second-largest acquisition in the Germany-based company’s history. And it follows the Novartis/GlaxoSmithKline whopper of a deal in Big Pharma announced just weeks ago. Even though Bayer’s paying more than 20 times earnings for Merck’s business, and many feel that’s too much, others like the deal, including Ulrich Huwald of Warburg Research: “Strategically, this is a consistent step for Bayer. The have a very strong brand, a clearly positive position in the over-the-counter business.” However, investors appear to be lining up opposite Ulrich on the deal, as BAYN shares are down since the announcement. What do you think?
Jim Woods has over 20 years of experience in the markets from working as a stockbroker, financial journalist, and money manager. As well as a book author and regular contributor to numerous investment websites, Jim is the editor of:
Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.
Jon Johnson's philosophy in investing and trading is to take what the market gives you regardless if that is to the upside or downside. For the past 21 years, Jon has helped thousands of clients gain success in the financial markets through his newsletters and education services:
George Gilder is the most knowledgeable man in America when it comes to the future of technology and its impact on our lives. He’s an established investor, bestselling author, and economist with an uncanny ability to foresee how new breakthroughs will play out, years in advance.
DayTradeSPY was founded by head trader Hugh Grossman, a retired internal auditor for a Fortune 500 company. After years of first-hand experience trying out one trading strategy after another, Hugh instead developed his own trading system centered around day trading SPY options. That’s it... Nothing else.